Octapeptide for SNARE-pathway cosmetic research.
SNAP-8 is an octapeptide analogue of the N-terminal region of SNAP-25 investigated for topical cosmetic research targeting expression-line attenuation.
Competes with SNAP-25 in the SNARE complex, reducing catecholamine-mediated neurotransmitter release in cultured neuronal models.
Peptide engages target receptor with high affinity.
Downstream intracellular pathways activate.
Gene expression and protein synthesis shift.
Measurable change in the studied biomarker.
Foundational anti-wrinkle pharmacology of SNAP-25-derived peptides.
Reduction in wrinkle depth at periorbital region vs. baseline.
Reviewed clinical evidence on argireline-class peptide efficacy.
Consistent modest improvements in expression-line metrics across trials.
Tested permeation enhancement strategies for SNAP-class peptides.
Demonstrated formulation-dependent stratum-corneum penetration.
Store at 2–8°C in dry, light-protected containers.
Strictly for in-vitro laboratory and research investigations.
Not approved for diagnostic, therapeutic, or veterinary application.
Handling restricted to licensed researchers and laboratory staff.
Warning — SNAP-8 is supplied solely for legitimate laboratory research. Any administration to humans or animals is strictly prohibited and may violate federal, state, or local law. By purchasing, the researcher accepts full responsibility for safe handling, storage, and lawful use.
